These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10945597)

  • 21. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
    Hsu NY; Ho HC; Chow KC; Lin TY; Shih CS; Wang LS; Tsai CM
    Cancer Res; 2001 Mar; 61(6):2727-31. PubMed ID: 11289154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
    Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopontin expression and prognostic significance in non-small cell lung cancer.
    Donati V; Boldrini L; Dell'Omodarme M; Prati MC; Faviana P; Camacci T; Lucchi M; Mussi A; Santoro M; Basolo F; Fontanini G
    Clin Cancer Res; 2005 Sep; 11(18):6459-65. PubMed ID: 16166420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer.
    Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
    Cancer Res; 2000 Jan; 60(2):242-4. PubMed ID: 10667567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma].
    Mauro LV; Dalurzo M; Smith D; Lastiri J; Vasallo B; Joffei EB; Pallotta MG; Puricelli L
    Medicina (B Aires); 2008; 68(3):205-12. PubMed ID: 18689151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.
    Marchetti A; Tinari N; Buttitta F; Chella A; Angeletti CA; Sacco R; Mucilli F; Ullrich A; Iacobelli S
    Cancer Res; 2002 May; 62(9):2535-9. PubMed ID: 11980646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
    Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer.
    Kawaguchi T; Sho M; Tojo T; Yamato I; Nomi T; Hotta K; Hamada K; Suzaki Y; Sugiura S; Kushibe K; Nakajima Y; Taniguchi S
    Jpn J Clin Oncol; 2010 Apr; 40(4):319-26. PubMed ID: 20085909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study.
    Yasuda M; Takesue F; Inutsuka S; Honda M; Nozoe T; Korenaga D
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):412-6. PubMed ID: 12200597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.
    Tanaka F; Otake Y; Nakagawa T; Kawano Y; Miyahara R; Li M; Yanagihara K; Inui K; Oyanagi H; Yamada T; Nakayama J; Fujimoto I; Ikenaka K; Wada H
    Cancer Res; 2001 Feb; 61(4):1666-70. PubMed ID: 11245481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.
    Katsimpoula S; Patrinou-Georgoula M; Makrilia N; Dimakou K; Guialis A; Orfanidou D; Syrigos KN
    Anticancer Res; 2009 Apr; 29(4):1373-82. PubMed ID: 19414390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
    Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review.
    Singhal S; Vachani A; Antin-Ozerkis D; Kaiser LR; Albelda SM
    Clin Cancer Res; 2005 Jun; 11(11):3974-86. PubMed ID: 15930332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of cyclin B1 protein expression in colorectal cancer.
    Grabsch H; Lickvers K; Hansen O; Takeno S; Willers R; Stock W; Gabbert HE; Mueller W
    Am J Clin Pathol; 2004 Oct; 122(4):511-6. PubMed ID: 15487447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
    Ferreira CG; van der Valk P; Span SW; Ludwig I; Smit EF; Kruyt FA; Pinedo HM; van Tinteren H; Giaccone G
    Clin Cancer Res; 2001 Aug; 7(8):2468-74. PubMed ID: 11489828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.